Search Results - "Sridhar, Sathvik B"

Refine Results
  1. 1

    A common molecular and cellular pathway in developing Alzheimer and cancer by Ali, Mohammad, Wani, Shahid Ud Din, Dey, Tathagata, Sridhar, Sathvik B., Qadrie, Zulfkar Latief

    Published in Biochemistry and biophysics reports (01-03-2024)
    “…Globally cancer and Alzheimer's disease (AD) are two major diseases and still, there is no clearly defined molecular mechanism. There is an opposite relation…”
    Get full text
    Journal Article
  2. 2

    Exploring pharmacovigilance practices and knowledge among healthcare professionals: A cross-sectional multicenter study by Hayek, Abdulkader, Sridhar, Sathvik B, Rabbani, Syed Arman, Shareef, Javed, Wadhwa, Tarun

    Published in SAGE open medicine (01-01-2024)
    “…Healthcare professionals' awareness of adverse drug reaction reporting and pharmacovigilance practices differ by country. The study assesses healthcare…”
    Get full text
    Journal Article
  3. 3

    The Effect of Polymers on Drug Release Kinetics in Nanoemulsion In Situ Gel Formulation by Vijaya Rani, K Reeta, Rajan, Sruthi, Bhupathyraaj, Mullaicharam, Priya, R Krishna, Halligudi, Nirmala, Al-Ghazali, Mohammad Abobakr, Sridhar, Sathvik B, Shareef, Javedh, Thomas, Sabin, Desai, Saleem M, Pol, Pandurang D

    Published in Polymers (21-01-2022)
    “…Glaucoma is an ocular condition characterized by elevated intraocular pressure (IOP). Conventional treatments of glaucoma face poor corneal permeability and…”
    Get full text
    Journal Article
  4. 4

    Assessment of Prescribing Practices and Factors Related to Antibiotic Prescribing in Community Pharmacies by Rabbani, Syed Arman, Sridhar, Sathvik B, Safdar, Maryam, Rao, Padma G M, Jaber, Ammar Ali Saleh, AlAhmad, Mohammad M, Shaar, Khaled, Emad, Israa, Azim, Muhammad Abdul

    Published in Medicina (Kaunas, Lithuania) (27-04-2023)
    “…: Overprescribing of antibiotics is one of the important contributors of antimicrobial resistance globally. A high proportion of antibiotics prescribed in…”
    Get full text
    Journal Article
  5. 5

    Effect of Polymers and Permeation Enhancers in the Release of Quetiapine Fumarate Transdermal Patch through the Dialysis Membrane by Bhupathyraaj, Mullaicharam, Vijaya Rani, K Reeta, Sridhar, Sathvik B, Shareef, Javed, Thomas, Sabin, Halligudi, Nirmala, Sockalingam, Anbazhagan, Mohandoss, Kiruba, Sundar, Shyam

    Published in Polymers (13-05-2022)
    “…Quetiapine Fumarate is potent, and the daily therapeutic dose can be delivered easily across the skin with the help of permeation enhancers. Quetiapine…”
    Get full text
    Journal Article
  6. 6

    Divine noni's protective impact on Swiss albino mice's short-term memory impairment caused by cyclophosphamide: A behavioral and biochemical approach by Ali, Mohammad, Din Wani, Shahid Ud, Manjula, S.N., Mruthunjaya, K., Shakeel, Faiyaz, DR, Bharathi, Sridhar, Sathvik B., Mohiuddin, Ishfaq, Mir, Reyaz Hassan, Dey, Tathagata

    Published in Heliyon (30-09-2024)
    “…Cyclophosphamide (CYL) is a first-line cancer chemotherapeutic agent widely used for the treatment of cancer that has severe toxic effects. The primary…”
    Get full text
    Journal Article
  7. 7

    Assessment of incidence, causality, severity, and preventability of suspected adverse drug reactions to antidepressant medications in a psychiatry outpatient setting of a secondary care hospital by Al Zaabi, Moza, Sridhar, Sathvik, Tadross, Talaat

    Published in Journal of pharmacy & bioallied science (01-04-2020)
    “…Background: Antidepressant medications are primarily used in the management of depression and various anxiety disorders. Antidepressant medications are known…”
    Get full text
    Journal Article
  8. 8

    Use of phosphate binders in end-stage renal disease: An experience from a secondary care hospital in United Arab Emirates by Rabbani, Syed, Sridhar, Sathvik, Rao, Padma, Kurian, Martin, Essawy, Basset

    Published in Journal of pharmacy & bioallied science (01-04-2019)
    “…Objective: Hyperphosphatemia in end-stage renal disease (ESRD) is associated with many serious patient-level consequences including cardiovascular events and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Physicians’ opinions on the utilization of generic medications in Gulf Cooperation Council countries: a narrative review by Rafiq, Rubina, Ooi, Guat See, Sridhar, Sathvik B, Ejaz, Haris

    “…Abstract Objective This review paper explores strategies and recommendations for reducing healthcare expenses in the Gulf Cooperation Council (GCC) by…”
    Get full text
    Journal Article
  11. 11

    Evaluation of potential drug-drug interactions and adverse drug reactions among chronic kidney disease patients: An experience from United Arab Emirates by Hammoud, Kowsar Mouhib, Sridhar, Sathvik B, Rabbani, Syed Arman, Kurian, Martin Thomas

    “…Purpose: To determine the prevalence and assessing nature of potential drug-drug interactions (pDDIs) and adverse drug reactions (ADRs) among chronic kidney…”
    Get full text
    Journal Article
  12. 12

    Scoping review of enablers and challenges of implementing pharmacogenomics testing in the primary care settings by Mai, Chun-Wai, Sridhar, Sathvik B, Karattuthodi, Mohammed Salim, Ganesan, Perishithaa M, Shareef, Javedh, Lee, E Lyn, Armani, Keivan

    Published in BMJ open (05-11-2024)
    “…Pharmacogenomic testing (PGx) plays a crucial role in improving patient medication safety, yet ethical concerns and limitations impede its clinical…”
    Get full text
    Journal Article
  13. 13

    From textbooks to online sources: An Investigation of drug information resource preference and utilization among healthcare Professionals by Hayek, Abdulkader, Sridhar, Sathvik B., Rabbani, Syed Arman, Shareef, Javed

    Published in Clinical epidemiology and global health (01-03-2024)
    “…Providing drug information (DI) is one of the essential pharmaceutical care services. Previous research has documented varying DI preferences and utilization…”
    Get full text
    Journal Article
  14. 14

    Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients by Shouqair, Tasneem M, Rabbani, Syed Arman, Sridhar, Sathvik B, Kurian, Martin T

    Published in Curēus (Palo Alto, CA) (10-04-2022)
    “…Background Chronic kidney disease (CKD) is a challenging global health problem with increasing prevalence worldwide. Concurrence of CKD and comorbidities…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Provision of clinical pharmacy education and services by RAK college of pharmaceutical sciences, Ras Al Khaimah, UAE by Francis, Smitha, Rao, Padma, Sridhar, Sathvik

    Published in Archives of pharmacy practice (01-07-2013)
    “…Objectives: Internationally, the role of pharmacist has now been extended from the provision of traditional services to patient specific care services. Unlike…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Management of severe hyponatremia in a chronic kidney disease patient; a case report by Qasem, Anass, Rabbani, Syed Arman, Kurian, Martin Thomas, Sridhar, Sathvik B

    Published in Journal of nephropharmacology (29-06-2024)
    “…Hyponatremia is a common electrolyte abnormality in chronic kidney disease (CKD). Managing severe hyponatremia in CKD is challenging, requiring the correction…”
    Get full text
    Journal Article
  19. 19
  20. 20